Afirka Ta Kudu Da Wasu ‘Yan Kolombiya Suna Yaki Da Masu Samar Da Magunguna

Afirka ta Kudu, Kolombiya da sauran ƙasashen da suka yi rashin nasara a tseren duniya na rigakafin cutar sankara na coronavirus suna ɗaukar ƙarin matakan yaƙi ga masu yin magunguna tare da ja da baya kan manufofin da ke hana arha magani ga miliyoyin mutanen da ke fama da tarin fuka da HIV.

 

Masana na ganin sauyi ne kan yadda irin wadannan kasashe ke mu’amala da magungunan kashe kwayoyin cuta kuma sun ce hakan na iya haifar da karin yunƙurin samar da magunguna na ceton rai.

 

A cikin cutar ta COVID-19, ƙasashe masu arziki sun sayi mafi yawan allurar rigakafin duniya da wuri, suna barin ‘yan harbi kaɗan ga ƙasashe matalauta tare da haifar da rarrabuwa Hukumar Lafiya ta Duniya da ake kira “mummunan gazawar ɗabi’a.”

 

Sauran ƙasashe suna ƙoƙarin zama masu dogaro da kansu “saboda sun fahimci bayan COVID ba za su iya dogaro da kowa ba,” in ji Brook Baker, wanda ke nazarin batutuwan samun magani a Jami’ar Arewa maso Gabas.

 

Ɗaya daga cikin abubuwan da aka yi niyya shine magani, bed aquiline, wanda ake amfani da shi don kula da mutanen da ke fama da nau’in tarin fuka.

 

Kwayoyin suna da mahimmanci musamman ga Afirka ta Kudu, inda tarin fuka ya kashe mutane sama da 50,000 a cikin 2021, wanda ya zama sanadin mutuwar kasar.

 

A cikin ‘yan watannin nan, masu fafutuka sun nuna rashin amincewarsu da kokarin da Johnson & Johnson ke yi na kare hakinta kan maganin.

 

A watan Maris, masu fama da tarin fuka sun kai kara ga gwamnatin Indiya, suna masu kira da a samar da kayayyaki masu rahusa; gwamnati a ƙarshe ta amince za a iya karya haƙƙin mallaka na J&J.

 

Belarus da Ukraine sun rubuta wa J&J, suna kuma neman ta da ta yi watsi da haƙƙin mallaka, amma da ɗan amsa.

 

A watan Yuli, lasisin J&J kan maganin ya kare a Afirka ta Kudu, amma kamfanin ya tsawaita shi har zuwa 2027, abin da ya fusata masu fafutuka da suka zarge shi da cin riba.

 

Daga nan sai gwamnatin Afirka ta Kudu ta fara binciken manufofin farashin kamfanin.

 

Ya kasance yana biyan kusan rand 5,400 ($282) a kowace kwas ɗin magani, fiye da sau biyu fiye da ƙasashen matalauta waɗanda suka sami maganin ta hanyar ƙoƙarin duniya da ake kira Haɗin gwiwa na Tarin Tarin Fuka.

 

 

A watan Satumba, kusan mako guda bayan fara binciken Afirka ta Kudu, J&J ya ba da sanarwar cewa za ta yi watsi da haƙƙin mallaka a cikin ƙasashe sama da 130, wanda ke ba masu kera magunguna damar kwafi.

 

“Wannan yana magance duk wani kuskuren cewa samun magungunan mu yana da iyaka,” in ji kamfanin.

 

Christophe Perrin, kwararre kan tarin fuka a Doctors Without Borders, ya kira juyewar J&J “babban abin mamaki” saboda kariyar haƙƙin mallaka shine yawanci “dutsen kusurwa” na dabarun kamfanonin harhada magunguna.

 

A halin da ake ciki, a Kolombiya, gwamnati ta ayyana a watan da ya gabata cewa za ta ba da lasisin dole don maganin cutar kanjamau na dolutegravir ba tare da izini daga mai mallakar maganin ba, Viv Healthcare.

 

Matakin ya zo ne bayan kungiyoyi sama da 120 sun nemi gwamnatin Colombia da ta fadada hanyoyin amfani da maganin da WHO ta ba da shawarar.

 

Peter Maybarduk na kungiyar fafutukar kare hakkin jama’a ta Washington ya ce “Wannan ita ce Colombia ke karbar ragamar mulki bayan matsanancin rashin adalci na COVID da kuma kalubalantar manyan magunguna don tabbatar da maganin cutar kanjamau mai araha ga mutanenta.”

 

Ya yi nuni da cewa, masu fafutuka na Brazil suna ingiza gwamnatinsu don yin irin wannan mataki.

 

Har yanzu, wasu ƙwararrun sun ce akwai buƙatar ƙarin canji kafin ƙasashe matalauta su iya samar da nasu magunguna da rigakafin.

 

Lokacin da cutar sankarau ta bulla, Afirka ta samar da kasa da kashi 1% na duk allurar rigakafin da aka yi a duniya amma ta yi amfani da fiye da rabin wadatar duniya, a cewar Petro Terblanche, manajan daraktan Afrigen Biologics. Kamfanin wani bangare ne na wani yunƙuri da WHO ke tallafawa don samar da rigakafin COVID ta amfani da fasahar mRNA iri ɗaya kamar waɗanda Pfizer da Moderna suka yi.

 

Terblanche ya kiyasta kimanin mutane miliyan 14 ne suka mutu sakamakon cutar kanjamau a Afirka a karshen shekarun 1990-2000, lokacin da kasashe suka kasa samun magungunan da suka dace.

 

A baya can, gwamnatin Shugaba Nelson Mandela a Afirka ta Kudu daga ƙarshe ta dakatar da haƙƙin mallaka don ba da damar yin amfani da magungunan AIDS mai yawa. Hakan ya sa masu yin magunguna sama da 30 suka gurfanar da shi a gaban kotu a shekarar 1998, a shari’ar da aka yi wa lakabi da “Mandela vs. Big Pharma.”

 

Kungiyar Doctors Without Borders ta bayyana lamarin a matsayin ” bala’in hulda da jama’a” ga kamfanonin magunguna, wanda ya janye karar a 2001.

 

 

Ladan Nasidi.